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The incidence of human papillomavirus (HPV) infection and cer-
vical cancer can be reduced by increasing vaccination for HPV.
Yet vaccination uptake and completion of the 3-dose series re-
main  low  among  Puerto  Rican  females.  This  study  explored
psychosocial factors associated with HPV vaccination uptake de-
cisions among Puerto Rican mothers and daughters.
Methods
We conducted 7 focus groups with young women aged 16 to 24 (n
= 21) and their mothers (n = 9) to assess knowledge, attitudes, and
beliefs related to cervical cancer, HPV, and HPV vaccination. We
analyzed the focus group transcripts and identified themes by us-
ing a constant comparison method of qualitative data analysis and
interpretation, guided by a grounded theory approach.
Results
The analysis identified several emergent themes related to vaccine
uptake: 1) low knowledge about cervical cancer, HPV, and the
HPV vaccine; 2) inconsistent beliefs about susceptibility to HPV
infection and cervical cancer; 3) vaccine effectiveness; 4) vaccine
safety and side effects;  5)  concerns that  the vaccine promotes
sexual disinhibition; and 6) availability of insurance coverage and
overall cost of the vaccine.
Conclusion
Our study found that adolescent girls and young women in Puerto
Rico have low levels of knowledge about HPV and cervical can-
cer, low perceived susceptibility to HPV, and concerns about the
safety and efficacy of the vaccine, and these factors may influence
uptake  and completion of  HPV vaccination.  Interventions  are
needed  for  both  mothers  and  daughters  that  address  these
psychosocial factors and increase access to vaccination.
Introduction
Hispanic women in the United States have higher rates of cervical
cancer (1) than women in other racial/ethnic groups. In Puerto
Rico, cervical cancer is the 6th most commonly diagnosed cancer
among women (2). Two vaccines, Gardasil and Cervarix, prevent
infections by high-risk human papillomavirus (HPV) types, which
cause most cervical cancers (3). Gardasil, approved in 2006, is re-
commended for both young men and young women, and protects
against HPV types 6, 11, 16, and 18; Cervarix, approved in 2009
for young women, protects against HPV types 16 and 18.
Rates of HPV vaccine initiation (51%) and completion (21%) are
lower among girls aged 11 to 18 years in Puerto Rico (4) com-
pared with young Hispanic women in the mainland United States
(62.9% initiating and 59.3% completing the series). This disparity
exists despite availability of free vaccination for children aged 11
to 18 years in Puerto Rico through several programs: Vaccines for
Children (VFC), the Puerto Rican governmental health insurance
plan (Mi Salud), and State Law no. 255, which mandates health
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insurance coverage of the HPV vaccine for girls and boys aged 11
to 18 years. Among US Hispanic women in the “catch-up” age
range (19–26 years), HPV vaccination initiation rates (18.7%) are
even lower than among adolescents (5). In Puerto Rico, programs
for free vaccination do not cover women aged 19 to 26. Some, but
not all, private insurance companies cover vaccination for women
in the catch-up age group. Mi Salud participants, the uninsured,
and those with medical insurance not covering the vaccination for
this age group, can obtain it at a cost of $100 to $110 per vaccine
dose at 6 vaccination centers across the island. Thus, access to
vaccination among women aged 19 to 26 may be influenced by
cost barriers.
Parental psychosocial factors that influence vaccination are know-
ledge (6–8), physician recommendation (9,10), and the belief that
vaccination will protect daughters against genital warts and cer-
vical cancer (6,10). Studies among women aged 18 to 26 (11,12)
and 19 to 26 (13) report that knowledge and awareness of HPV
(11), beliefs and attitudes about HPV vaccine (13), access to trans-
portation (12), and prioritizing health over other daily responsibil-
ities (12) are associated with vaccine uptake.
Research among Hispanic mothers and daughters in the United
States (6,14) revealed key predictors of vaccine uptake, but in-
formation  about  psychosocial  factors  influencing  vaccination
among women in Puerto Rico is not available. Although young
women aged 19 to 26 may have more autonomy in HPV vaccine
decision-making than do underage girls, they may still rely on par-
ental input or financial support for vaccination. The purpose of
this study was to explore factors influencing HPV vaccine initi-
ation decisions by mothers and daughters in Puerto Rico.
Methods
Recruitment announcements were posted throughout hospitals and
clinics at San Juan Medical Center and in communities identified
through our outreach network (15). We recruited young women
aged 16 to 26 and mothers of daughters in the same age range. Al-
though recruitment efforts targeted fathers and mothers, except for
one father, all participants were mothers. We removed the father’s
data from the analysis for consistency and analyzed only data from
mothers. Other eligibility criteria included daughters’ knowledge
of their own HPV vaccination status, mothers’ knowledge of their
daughters’ HPV vaccination status and no history of cervical can-
cer for either group. Among 44 eligible mothers and young wo-
men, 30 (68%) agreed to participate. Participants were assigned to
a daughter- or mother-focus group and were stratified by HPV
vaccination status (daughter had at least one HPV vaccine, and
those never vaccinated). All mothers had daughters that particip-
ated in the young women’s groups. However, some young women
did not have their mother in the parents’ groups. The institutional
review boards of the University of Texas Health Science Center
and the University of Puerto Rico Medical Sciences Campus ap-
proved the study protocol.
We conducted 7 focus groups during April through June 2010: 4
with young women (n = 21) and 3 with mothers (n = 9). Three
groups  consisted  of  unvaccinated  daughters  (n  =  16)  and  one
group consisted of vaccinated daughters (n = 5). Two parental
groups had unvaccinated daughters (n = 6) and one group had vac-
cinated daughters (n = 3). Group discussions were held at an aca-
demic institution in the San Juan Medical Center. The study team
adapted an existing interview guide (Box 1) from a previous study
(6). The facilitator described the study and obtained informed con-
sent. Women younger than 18 years provided a parent-signed in-
formed consent and their assent to participate. All participants
completed a short demographic questionnaire. Female facilitators
conducted the 1-hour focus groups in Spanish. Following the dis-
cussion, participants received educational materials about HPV
and  cervical  cancer,  along  with  $20  as  compensation.  Focus
groups were audio-recorded, transcribed, and entered into Atlas.ti
(ATLAS.ti GmbH) for analysis.
Box 1. Interview Questions From Focus Groups Conducted in Pu-
erto Rico With Mothers and Daughters About Their Knowledge, At-






What do you think when you hear cervical
cancer?
What do you know about cervical cancer?
What causes cervical cancer?
Who can have cervical cancer?
Do you think there is a possibility your
daughter may have cervical cancer in the
future? Why? Why not?
(Daughters’ groups only) Do you think
there is a possibility you may have cervical
cancer in the future? Why? Why not?
Awareness and
knowledge of HPV
and the HPV vaccine
Have you heard about the human
papilloma virus (HPV)?
Where did you hear about it?
Who could get HPV?
(Daughters’ groups only) Do you think you
could get infected with HPV?
Have you heard about the HPV vaccine?
What do you know about the HPV vaccine?
Attitudes toward the
HPV vaccine
What do you think about vaccinating your
daughter? Why? Why not?
PREVENTING CHRONIC DISEASE VOLUME 11, E212
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY   DECEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
2       Centers for Disease Control and Prevention  •  www.cdc.gov/pcd/issues/2014/14_0171.htm
Topic Question
What reasons do you have for vaccinating
or not vaccinating your daughter?
What concerns would you have about
vaccinating your daughter? What
information would you need to make a
decision?
(Daughters’ groups only) What do you
think about getting vaccinated?
(Daughters’ groups only) What do you
think would be the benefits of getting
vaccinated?
(Daughters’ groups only) What concerns
would you have about getting the HPV
vaccine?
The lead author and 3 coders read all transcripts and began coding
by using a constant comparison method, consistent with a groun-
ded theory approach (16). Coders read and coded the same tran-
script, and then discussed identified themes and produced a base
set of codes to use for the remaining transcripts. The analysis team
met biweekly to discuss new themes and to come to consensus on
new codes and coding discrepancies.
Results
The analysis of the focus group transcripts allowed us to identify
several emergent themes related to vaccine uptake: 1) low know-
ledge about cervical cancer, HPV, and the HPV vaccine; 2) incon-
sistent beliefs about susceptibility to HPV infection and cervical
cancer; 3) misconceptions about vaccine effectiveness; 4) concern
about vaccine safety and side effects; 5) concern that the vaccine
promotes sexual disinhibition; and 6) lack of insurance coverage
and overall cost of the vaccine (Box 2). Daughters’ mean age was
20.4 years (standard deviation [SD], 3.8 y) and mothers’ was 47.9
years (SD, 5.5 y). Most daughters had completed 1 or more years
of college education (67%); 86% of mothers had a bachelor’s or
advanced degree.  All  daughters had health insurance.  Slightly
more than half (55%) of participants reported a family income be-
low $40,000 annually.
Box 2. Additional Quotes From Focus Groups Conducted in Puerto
Rico With Mothers and Daughters About Their Knowledge, Atti-
tudes, and Beliefs About Human Papillomavirus (HPV) Vaccination,
2010
Theme Example Quote Group
Low knowledge “I know it [cervical cancer] Vaccinated




develops in the cervix, but I don’t
know anything else about it.”
daughter
“I know it’s caused by the human




Who can get cervical cancer?




“I don’t know how to explain it
[cervical cancer] because I don’t




“I think that once they tell you
that [cervical cancer diagnosis]
they have to get everything out




“I have heard about it [HPV], but
I don’t know what it is.”
Vaccinated
daughter
“I was once at a store . . . when I
went to try the bra the sales clerk
told me ‘No, because there is a
new virus, HPV, and you can’t [try




“I have heard that like other
cancers its [cervical cancer]
origin is not known. I know some
are treatable if found early, even
cervical cancer, but I don’t have





What is the most important
factor that influenced your
decision of not vaccinating your
daughter? “Complete lack of
knowledge. I don’t know the




“Gardasil can prevent infection,
but it has a target . . . I








“They are still doing the studies
and I might be somewhat




“I don’t know how long the doses




“So I’m not sure if they
[daughters] can get it if they
have had sex already or should





Concerns “Everything has a risk, every Vaccinated
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vaccine has side effects.” daughter
“It’s new and some things
haven’t come out yet, like side




“At that moment I was worried
that something would happen to





“And what about if this vaccine











“She [mother] thinks that if she
vaccinates her daughter or she
tells her [about the vaccine] it
would be giving her the green
light, ‘you can do it [sex].’”
Vaccinated
daughter
“Now she will become sexually










“It’s hard because you say it is
one hundred dollars the first
dose, ok we get the hundred
dollars. But for this next date you
need to have another hundred
dollars so some people may say




“I went to the clinic to find out
when I was due for vaccines, but
my mom didn’t want me to get




“My kids’ pediatrician offered me
the vaccine for them, but I didn’t
get it because it’s three hundred
dollars each dose and the




Low knowledge about cervical cancer and HPV
Young women. Few participants from either group said that cer-
vical cancer is caused by HPV, multiple sexual partners, or lack of
routine  screening.  Unvaccinated  women had  little  knowledge
about HPV or the vaccine. They said that cervical cancer is caused
by genetic predisposition, use of birth control pills, lack of hy-
giene, poor diet, and lack of physical activity. Misconceptions in-
cluded that HPV could be transmitted by sharing a bathing suit or
soap. Most participants had not heard about the vaccine and could
not describe vaccination guidelines. One participant noted that wo-
men do not receive information from their gynecologists about the
vaccine.
Mothers.  Most mothers had difficulty explaining what cervical
cancer is and suggested several causes, including HPV, genetic
predisposition, promiscuity, and early initiation of sexual activity.
Some mothers of unvaccinated girls also said that cervical cancer
is fatal “like HIV.” With one exception, all mothers said that regu-
lar Papanicolaou (Pap) tests could detect cervical cancer. Only one
mother knew that HPV is sexually transmitted. Most mothers of
unvaccinated daughters believed that HPV affects only women.
Many mothers expressed not knowing enough about the vaccine,
including vaccination guidelines,  and most  wondered whether
girls  could still  get  the vaccine after  they had initiated sexual
activity.
Susceptibility to cervical cancer and HPV infection
Young women. Regardless of their vaccination status, most young
women said “anyone is at risk of [cervical] cancer,” including
themselves. When asked about HPV, some vaccinated daughters
indicated that their risk for getting HPV is low because “they got
the vaccine.” Others still felt at risk because the vaccine “only
covers a few types of HPV.” Unvaccinated young women noted
“you are never exempt.” A younger unvaccinated participant in-
dicated not feeling at risk for HPV because she is not sexually act-
ive.
Mothers.  When mothers were asked if they felt their daughters
were at risk for cervical cancer, some indicated that they “don’t
think about this.” Mothers with unvaccinated daughters were more
likely to discuss reasons why their daughters were not at risk, in-
cluding their belief that they were not sexually active. One mother
highlighted the distinction between what she thought other girls
were doing (being sexually active at a young age) in contrast to
her daughter. “It’s about lifestyle; I think that girls can be at risk if
they are sexually active. I’m a high school teacher and I know that
more than 50% are sexually active; my three daughters are not.
We have talked about it with openness and honesty . . . our family
values are very different from those of the girls I teach.”
Concerns about vaccine efficacy
Young women. Some young women were not sure whether the
vaccine would be effective if they had already had sexual rela-
tions: “I think that people our age would say ‘it’s not useful for
me, I’m already sexually active,’ since the vaccine is advertised
for people who haven’t yet.” Participants also expressed doubts
about the [HPV] vaccine’s effectiveness in general: “I haven’t
heard about how effective the vaccine is . . . or about the probabil-
ity of decreasing my risk of infection if I vaccinate now.” Other
young women wondered how long the vaccine’s protection lasted.
Others shared this confusion and concern that they may not be
protected in the future.
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Mothers. Some mothers expressed hesitation about vaccinating
their daughters and alluded to the unknowns about effectiveness.
One mother said that she vaccinated her children with all the re-
quired vaccines to enter school but she is “not convinced” of the
efficacy of the HPV vaccine. Others said that if it is so important,
the government should “take action to educate the community.”
Their perception was that since the HPV vaccine was not publi-
cized much, it must not be important or efficacious.
Concerns about vaccine safety
Young women.  Most  vaccinated young women were  not  con-
cerned about the vaccine’s potential side effects. One participant
said that “everything has risks and I think the benefits outweigh
the risks.” Only one young woman expressed fear because she had
read an article highlighting some deaths among vaccinated girls.
Unvaccinated women mentioned several concerns including ac-
quiring another illness as an effect of the vaccine and unknown
long-term side effects: “I would have to know what the risks are
so I won’t be preventing one illness, but getting other [illnesses].”
Another participant responded, “It’s new and some things haven’t
come  out  yet,  like  side  effects,  so  I  wait  years  before  trying
something new.”
Mothers. Mothers of vaccinated girls were concerned that the vac-
cine would leave daughters sterile or cause another illness and that
the  vaccine  was  still  being  researched so  daughters  would  be
“guinea pigs.” Mothers with unvaccinated daughters had more
concerns than those who had vaccinated daughters. Concerns were
unknown side effects, unknown level of safety, and fear that the
vaccine has not been researched enough. One participant men-
tioned: “I have doubts, I talk with my cousin and she says that side
effects are still unknown, that it is not safe, and that we have to
wait.”
Concerns about the vaccine promoting sexual
disinhibition
Young women.  In  general,  daughters  did  not  agree  with  their
mothers’ concern that getting vaccinated was giving them permis-
sion to be sexually active. They said “it’s not giving permission;
it’s protecting your child.” Young women were more likely to
agree that younger girls (even aged 9) should be vaccinated to be
protected before becoming sexually active. They also noted that if
mothers don’t want to vaccinate daughters, it should really be the
daughter’s decision. Most said 16 or 17 years of age would be an
appropriate age for girls to make their own decision about vaccin-
ation.
Mothers. Some mothers worried that HPV vaccination would send
daughters the message that it was “ok” to have sex and if daugh-
ters believed they were protected from HPV, they would feel free
to have sex. One participant said: “I don’t know to what extent a
girl that’s 9 years old might assume ‘oh I’m protected; now I can
have sex’.  So you really have to be careful  at  this  age.” Most
mothers across groups believed that the appropriate age to vaccin-
ate daughters is when they enter high school or college.
Overall cost of the vaccine and availability of
insurance coverage
Young women. Young, unvaccinated women highlighted finan-
cial barriers and noted that “although many people want to obtain
the vaccine, they can’t pay for it” or “we would have to pay a high
deductible.” Indeed, a vaccinated participant responded that hav-
ing access to free vaccination through health insurance was an im-
portant factor in her vaccination: “[I] did not have any inconveni-
ence; the health insurance covered the full price of the vaccine.”
Mothers. Mothers noted that they couldn’t afford the vaccine. One
mother said: “the pediatrician recommended the vaccine for my
kids, but I didn’t vaccinate them because of the cost; the health in-
surance does not cover it.” Another mother of a vaccinated parti-
cipant stated that “without insurance covering the HPV vaccine
she could not afford the vaccine.”
Discussion
This study explored psychosocial  factors influencing the HPV
vaccination decisions of mothers and daughters living in Puerto
Rico. Although several of our findings are similar to those of oth-
er studies (6,14,17), we identified unique factors and possible dif-
ferences in the degree of importance for some of the common
ones. For example, despite high levels of education and income
among our participants,  their  knowledge about HPV and HPV
vaccination was low, especially among mothers.  Additionally,
their concerns about vaccine efficacy and, to some extent, safety
seemed to be associated with their perception that the HPV vac-
cine had neither been promoted in Puerto Rico nor recommended
by their providers.
Provider recommendation, a factor that influences vaccine de-
cisions (17,18), may be of particular relevance in Puerto Rico.
Studies on role preference in health care decision-making show
that Hispanic patients often prefer that providers take the lead in
making health care decisions (19). This situation may translate in-
to less willingness to ask a provider to vaccinate their daughters
and less willingness to engage in health-related behaviors without
explicit recommendations from providers.
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Mothers expressed reluctance to vaccinate younger daughters and
did not understand the benefit of HPV vaccination before initi-
ation of sexual activity. Maternal concerns that HPV vaccination
would promote sexual disinhibition have been reported elsewhere
(20,21). In a study with Latina parents in 3 different regions of the
United States, concern about HPV vaccination promoting sexual
disinhibition ranged from 11% in Los Angeles to 60% in Seattle
(17). Prior work also has shown that this concern is more likely
among older parents and those reporting conservative views (4).
However, increased knowledge about the HPV vaccine decreases
the likelihood of having this belief (21).
Mothers also expressed concerns regarding vaccine efficacy and
safety. Other studies with Hispanic populations reported similar
concerns (6,8,10). Low immunization rates overall in Puerto Rico
(measles, mumps, and rubella [MMR], 85.2%; diphtheria, tetanus,
and pertussis [DTaP], 81.9%; varicella [chickenpox], 88.7%) (4)
may be related to concerns about the overall safety of vaccines and
should be considered a contextual factor in mothers’ reluctance to
have their daughters vaccinated for HPV. Although some daugh-
ters, particularly unvaccinated ones, had concerns, they generally
had a better understanding of the need for vaccination and recog-
nized the benefits of following recommended HPV vaccination
guidelines.
This study has some limitations. Given the nature of qualitative in-
quiry, results are not generalizable to all women in Puerto Rico.
Additionally, participants were of higher socioeconomic status
than the  general  population in  Puerto  Rico.  For  2008 through
2012, the annual median household income in Puerto Rico was
$19,515 (22), whereas in our study 75% of the young women and
all of the mothers had a yearly income of $20,000 or higher. Al-
though 67% of the young women in the groups had at least 1 year
or more of college education, only 27.8% of young people aged 18
to 24 in Puerto Rico had completed high school. Nevertheless,
even with higher education and income levels, knowledge of HPV
and the vaccine was still low. Young women and mothers may
now have different or additional concerns than participants in our
study in 2010. However, since HPV vaccination rates are still low,
probably for many of the same reasons (4), we believe our study
findings provide a valuable contribution to the factors associated
with low levels of HPV vaccination in Puerto Rico.
Our findings are consistent with those of other studies, yet some
factors varied in the degree of importance for Puerto Ricans. In-
creasing the level of HPV vaccination may not necessitate new in-
terventions that are vastly different from those developed for oth-
er groups. Instead, moderate adaptation of interventions may make
them more relevant for Puerto Rican women. For example, given
mothers’ doubts about vaccine efficacy due to low recommenda-
tion and promotion of the vaccine, messages focusing on vaccine
efficacy, recommendations from providers, and increased promo-
tion of the HPV vaccine may be warranted. Additionally, because
mothers seem to be involved in the vaccine decision for economic
or  cultural  reasons,  interventions  focusing  on  communication
between mothers and daughters about HPV may increase vaccina-
tion. Modifying promotional materials to match them with Puerto
Rican    culture may also be warranted. A recent study (15) that
explored the role of ethnic identity on attitudes toward HPV vac-
cine  advertising  noted  that  Puerto  Rican  participants  did  not
identify with many of the HPV vaccine campaigns because the
actors’ facial characteristics and language were not Puerto Rican.
Participants also did not feel at the same risk levels as the indi-
viduals portrayed in the advertisements (15).
Our study is the first to provide insight into common psychosocial
barriers  affecting HPV vaccination in  Puerto  Rico and under-
scores the need for increased education about HPV vaccination,
provider recommendations, and access to low-cost vaccines, simil-
ar to findings reported from other studies (17,23–26). Future inter-
ventions should address knowledge regarding HPV vaccination ef-
fectiveness and safety, the rationale behind HPV vaccination for
young age groups, and the potential benefits for vaccinating young
women in the catch-up age range. The Community Cancer Con-
trol Outreach Program, the Cancer Center Coalition at the Uni-
versity of Puerto Rico, and the Puerto Rico Comprehensive Can-
cer Center are implementing initiatives that translate such find-
ings into messages and strategies to promote HPV vaccination
throughout Puerto Rico.
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